In breast cancer, we observed that GSDMD was expressed both in cancer cells and in the microenvironment, including endothelial cells, fibroblasts and most immune cell types, such as myeloid cells and B and T lymphocytes (Figure 2A). Here, GSDMD is linked to breast carcinoma.